Yesterday, Aug. 24, 2015, 130 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $548.22 to $210,501,361.00.

Highlighted Stocks Traded by Insiders:

MasTec (MTZ) - FREE Research Report

Pita George, who is Cfo at MasTec, bought 5,000 shares at $16.00 on Aug. 24, 2015. Following this transaction, the Cfo owned 95,614 shares meaning that the stake was boosted by 5.52% with the 5,000-share transaction.

The shares most recently traded at $15.32, down $0.68, or 4.44% since the insider transaction. Historical insider transactions for MasTec go as follows:

  • 4-Week # shares sold: 11,324
  • 12-Week # shares sold: 11,324
  • 24-Week # shares sold: 11,324

The average volume for MasTec has been 1.3 million shares per day over the past 30 days. MasTec has a market cap of $1.2 billion and is part of the industrial goods sector and materials & construction industry. Shares are down 34.1% year-to-date as of the close of trading on Monday.

MasTec, Inc., an infrastructure construction company, provides engineering, building, installation, maintenance, and upgrade services for communications, energy, and utility infrastructure in the United States and internationally. The company has a P/E ratio of 20.0. Currently, there are 7 analysts who rate MasTec a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on MTZ - FREE

TheStreet Quant Ratings rates MasTec as a hold. The company's strongest point has been its a solid financial position based on a variety of debt and liquidity measures that we have looked at. At the same time, however, we also find weaknesses including a generally disappointing performance in the stock itself, feeble growth in the company's earnings per share and deteriorating net income. Get the full MasTec Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

UDR (UDR) - FREE Research Report

OShields William T III, who is VP - Enterprise Risk Mgmt at UDR, sold 1,000 shares at $35.05 on Aug. 24, 2015. Following this transaction, the VP - Enterprise Risk Mgmt owned 6,021 shares meaning that the stake was reduced by 14.24% with the 1,000-share transaction.

The shares most recently traded at $32.08, down $2.97, or 9.27% since the insider transaction. Historical insider transactions for UDR go as follows:

  • 4-Week # shares sold: 80,802
  • 12-Week # shares sold: 80,802
  • 24-Week # shares sold: 92,802

The average volume for UDR has been 1.8 million shares per day over the past 30 days. UDR has a market cap of $8.8 billion and is part of the financial sector and real estate industry. Shares are up 4.09% year-to-date as of the close of trading on Monday.

UDR, Inc. is an independent real estate investment trust. The firm invests in the real estate markets of the United States. It owns, operates, acquires, renovates, develops, redevelops, and manages multifamily apartment communities. The stock currently has a dividend yield of 3.28%. The company has a P/E ratio of 32.9. Currently, there are 7 analysts who rate UDR a buy, no analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on UDR - FREE

TheStreet Quant Ratings rates UDR as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, revenue growth and good cash flow from operations. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full UDR Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Chemed (CHE) - FREE Research Report

Grace Patrick P, who is Director at Chemed, sold 450 shares at $141.10 on Aug. 24, 2015. Following this transaction, the Director owned 4,572 shares meaning that the stake was reduced by 8.96% with the 450-share transaction.

The shares most recently traded at $138.92, down $2.18, or 1.57% since the insider transaction. Historical insider transactions for Chemed go as follows:

  • 4-Week # shares sold: 17,019
  • 12-Week # shares sold: 22,019
  • 24-Week # shares sold: 27,924

The average volume for Chemed has been 150,800 shares per day over the past 30 days. Chemed has a market cap of $2.4 billion and is part of the health care sector and health services industry. Shares are up 30% year-to-date as of the close of trading on Monday.

Chemed Corporation provides hospice and palliative care services in the United States. It operates in two segments, VITAS and Roto-Rooter. The company offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. The stock currently has a dividend yield of 0.68%. The company has a P/E ratio of 23.5. Currently, there is 1 analyst who rates Chemed a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on CHE - FREE

TheStreet Quant Ratings rates Chemed as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, increase in net income, revenue growth and notable return on equity. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full Chemed Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.